CARNITOR (levocarnitine) Leadiant biosci inc Patent: 6,696,493 Expiration: Jan 18, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dr…
Drug Patent Expirations for the Week of January 17, 2021 Read Post »
Annual Drug Patent Expirations for CARNITOR Carnitor is a drug marketed by Leadiant Biosci Inc and is included in three NDAs. It is available from two suppliers. There are three…
The post New patent expiration for Leadiant Biosci drug CARNITOR appeared…
New patent expiration for Leadiant Biosci drug CARNITOR Read Post »
Annual Drug Patent Expirations for CARNITOR Carnitor is a drug marketed by Leadiant Biosci Inc and is included in three NDAs. It is available from two suppliers. There are three…
The post New patent expiration for Leadiant Biosci drug CARNITOR appeared…
New patent expiration for Leadiant Biosci drug CARNITOR Read Post »
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER (esmolol hydrochloride) Hq spclt pharma Patent: 6,528,540 Expiration: Jan 12, 2021 See More … For more information on how DrugPatentWatch can help with…
The post Drug Patent Expirations for the…
Drug Patent Expirations for the Week of January 10, 2021 Read Post »
Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+DOUBLE+STRENGTH+IN+PLASTIC+CONTAINER Esmolol Hydrochloride Double Strength In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. It is available…
The post New pat…
Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+IN+PLASTIC+CONTAINER Esmolol Hydrochloride In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. It is available from one…
The post New patent expiration for Hq S…
New patent expiration for Hq Spclt drug ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER Read Post »
Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Clovis Oncology Inc and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent expiration for Clovis Oncology drug RUBRACA appeared first…
New patent expiration for Clovis Oncology drug RUBRACA Read Post »
Annual Drug Patent Expirations for ADDERALL+20 Adderall 20 is a drug marketed by Teva Womens and is included in one NDA. There is one patent protecting this drug. The generic…
The post New patent expiration for Teva Womens drug ADDERALL 20 appeared fir…
New patent expiration for Teva Womens drug ADDERALL 20 Read Post »
Annual Drug Patent Expirations for ADDERALL+5 Adderall 5 is a drug marketed by Teva Womens and is included in one NDA. There is one patent protecting this drug. The generic…
The post New patent expiration for Teva Womens drug ADDERALL 5 appeared first …
New patent expiration for Teva Womens drug ADDERALL 5 Read Post »
Annual Drug Patent Expirations for ADDERALL+30 Adderall 30 is a drug marketed by Teva Womens and is included in one NDA. There is one patent protecting this drug and one…
The post New patent expiration for Teva Womens drug ADDERALL 30 appeared first on…
New patent expiration for Teva Womens drug ADDERALL 30 Read Post »